129 related articles for article (PubMed ID: 37817523)
1. Targeting the AKT/mTOR/p70S6K Pathway for Oligodendrocyte Differentiation and Myelin Regeneration in Neurological Disorders.
Ge C; Li C
Curr Neurovasc Res; 2023; 20(4):453-463. PubMed ID: 37817523
[TBL] [Abstract][Full Text] [Related]
2. The promotive effect of activation of the Akt/mTOR/p70S6K signaling pathway in oligodendrocytes on nerve myelin regeneration in rats with spinal cord injury.
Ge C; Liu D; Sun Y
Br J Neurosurg; 2024 Apr; 38(2):284-292. PubMed ID: 33345640
[TBL] [Abstract][Full Text] [Related]
3. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
4. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin-1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury.
Ding Z; Dai C; Zhong L; Liu R; Gao W; Zhang H; Yin Z
Biomed Pharmacother; 2021 Feb; 134():111168. PubMed ID: 33395598
[TBL] [Abstract][Full Text] [Related]
6. Insulin growth factor-1 enhances proliferation and inhibits apoptosis of neural progenitor cells by phosphorylation of Akt/mTOR/p70S6K molecules and triggering intrinsic apoptosis signaling pathway.
Zhang B; Hu L; Zhang J; Wu H; Li W; Gou L; Liu H
Cell Tissue Bank; 2022 Sep; 23(3):459-472. PubMed ID: 34494222
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of erythropoietin-induced M2 microglia polarization via Akt / Mtor / P70S6k signaling pathway in the treatment of brain injury in premature mice and its effect on biofilm.
Wu X; Wang B; Ma Q; Zhang Y; Xu J; Zhang Z; Chen G
Bioengineered; 2022 May; 13(5):13021-13032. PubMed ID: 35611764
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination.
Musah AS; Brown TL; Jeffries MA; Shang Q; Hashimoto H; Evangelou AV; Kowalski A; Batish M; Macklin WB; Wood TL
J Neurosci; 2020 Apr; 40(15):2993-3007. PubMed ID: 32139584
[TBL] [Abstract][Full Text] [Related]
9. The Akt/mTOR/p70S6K Pathway Is Involved in the Neuroprotective Effect of Erythropoietin on Hypoxic/Ischemic Brain Injury in a Neonatal Rat Model.
Lee HJ; Koh SH; Song KM; Seol IJ; Park HK
Neonatology; 2016; 110(2):93-100. PubMed ID: 27070481
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.
Maki T; Takahashi Y; Miyamoto N; Liang AC; Ihara M; Lo EH; Arai K
Stem Cell Res; 2015 Jul; 15(1):68-74. PubMed ID: 26002630
[TBL] [Abstract][Full Text] [Related]
11. Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn.
Xu JT; Zhao X; Yaster M; Tao YX
Brain Res; 2010 Jun; 1336():46-57. PubMed ID: 20399760
[TBL] [Abstract][Full Text] [Related]
12. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.
Tyler WA; Gangoli N; Gokina P; Kim HA; Covey M; Levison SW; Wood TL
J Neurosci; 2009 May; 29(19):6367-78. PubMed ID: 19439614
[TBL] [Abstract][Full Text] [Related]
13. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
[TBL] [Abstract][Full Text] [Related]
14. The Akt-mTOR Pathway Drives Myelin Sheath Growth by Regulating Cap-Dependent Translation.
Fedder-Semmes KN; Appel B
J Neurosci; 2021 Oct; 41(41):8532-8544. PubMed ID: 34475201
[TBL] [Abstract][Full Text] [Related]
15. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury.
Labombarda F; González SL; Lima A; Roig P; Guennoun R; Schumacher M; de Nicola AF
Glia; 2009 Jun; 57(8):884-97. PubMed ID: 19053058
[TBL] [Abstract][Full Text] [Related]
16. The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation.
Ornelas IM; Khandker L; Wahl SE; Hashimoto H; Macklin WB; Wood TL
Glia; 2020 Jun; 68(6):1274-1290. PubMed ID: 31904150
[TBL] [Abstract][Full Text] [Related]
17. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
Tian J; Wang Y; Guo H; Li R
Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
[TBL] [Abstract][Full Text] [Related]
18. Glial and Neuronal Protein Tyrosine Phosphatase Alpha (PTPα) Regulate Oligodendrocyte Differentiation and Myelination.
Shih Y; Ly PTT; Wang J; Pallen CJ
J Mol Neurosci; 2017 Aug; 62(3-4):329-343. PubMed ID: 28647856
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.
Wahl SE; McLane LE; Bercury KK; Macklin WB; Wood TL
J Neurosci; 2014 Mar; 34(13):4453-65. PubMed ID: 24671992
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
